Image
Evidence-Based Best Practices™

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Practice Guidelines

 

Testing Recommendations for Hepatitis C Virus Infection

Centers for Disease Control and Prevention.

A Guide to Comprehensive Hepatitis C Counseling and Testing.

Centers for Disease Control and Prevention.

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.

American Association for the Study of Liver Diseases/Infectious Diseases Society of America, 2017.

Hepatitis C in Pregnancy: Screening, Treatment, and Management.

Society for Maternal-Fetal Medicine

Hepatitis B and Hepatitis C in Pregnancy.

The American College of Obstetricians and Gynecologists

Hepatitis C: Screening.

U.S. Preventive Services Task Force, 2013.

Viral Hepatitis Surveillance - United States, 2015.

Centers for Disease Control and Prevention, 2015.

Suggested Readings

Suggested Reading

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland.

Aebi-Popp K, et al. J Virus Erad. 2016;2(1):52-54.

Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.

Karampatou A, et al. J Hepatol. 2018;68(1):33-41.

Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.

Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.

National Viral Hepatitis Action Plan 2017–2020.

U.S. Department of Health and Human Services, 2017.

The HCV care continuum does not end with cure: a call to arms for the prevention of reinfection.

Falade-Nwulia O, Sulkowski M. J Hepatol. 2017;66(2):267-269.

Treatment of HCV in persons who inject drugs: treatment as prevention.

Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.

Patient Resources

Patient Education Resources.

Centers for Disease Control and Prevention

Fact sheets for patients.

Hepatitis C and Injection Drug Use.

This webpage provides concise information regarding HCV risk, transmission, and prevention in people who inject drugs.

Relevant Resources

Acute Management of Migraine Attacks

Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes

Clinical Updates on the Management of Gout

Evidence-Based Strategies for Improved Patient Outcomes

Opioid-Induced Constipation

Proactive Diagnosis and Targeted Management

Chronic Obstructive Pulmonary Disease, Asthma, or Both

Differential Diagnosis and Comprehensive Management Strategies

Improving Outcomes in Chronic Obstructive Pulmonary Disease

Optimizing Maintenance Therapy Across Healthcare Settings

Managing Gout in Primary Care

Evolving Strategies for Diagnosis and Long-Term Management

Clinical Issues in Chronic Pain

Consensus and Controversies for Responsible Opioid Prescribing

Noninsulin Approaches to Managing Type 2 Diabetes

Best Practices in Combination Therapy

Hitting the Target in Type 2 Diabetes

Evolving Approaches to Insulin Based Therapy

Clearing the Air

Improving Outcomes for Patients with COPD

Clinical Updates in Type 2 Diabetes

New Strategies for Insulin Replacement Therapy

How Low Do You Go?

Clinical Updates in LDL-C Management

Incretin-Based Therapies For Type 2 Diabetes

Improving Comprehensive Patient Care

Improving Outcomes in Non–24-Hour Sleep-Wake Disorder

Identifying Patients and Tailoring Therapy

Comprehensive Management of Chronic Obstructive Pulmonary Disease

Collaborative Approaches to Guideline-Concordant Patient Care

Clinical Updates in the Management of Severe Asthma

New Strategies for Individualizing Long-term Care

Comprehensive Chronic Pain Management

A Focus on Patients With Opioid-Induced Constipation

Clinical Issues in Bipolar Depression

Consensus and Controversies Across the Spectrum of Patient Presentations

Clinical Updates in Rheumatoid Arthritis

Evolving Treatment Algorithms and Expert Perspectives on Biosimilars

Caring for Patients with Severe Asthma

Evolving Best Practices to Optimize Outcomes

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Can You Spot Axial Spondyloarthritis?

The PCP’s Role in Timely Recognition and Referral

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Targeting NASH

Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

BLOCK HIV/HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

The Nexus of NASH and Type 2 Diabetes Mellitus

The Emerging Role of the Diabetologist

Advancing the Care of Severe Asthma

Differential Diagnosis, Multidisciplinary Management, and Patient Engagement